Premium
Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment
Author(s) -
Chen Jern Yee,
Chappell Angela J,
Klebe Sonja,
Mills Richard A
Publication year - 2007
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/j.1442-9071.2007.01640.x
Subject(s) - medicine , atypia , mitomycin c , conjunctiva , melanosis , cornea , dermatology , melanoma , pathology , ophthalmology , surgery , cancer research
A bstract The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established. This case report describes successful treatment of PAM with atypia with a single four day cycle of 0.02% MMC.